Drawing for CELLGRAFT

USPTO serial 79170560

CELLGRAFT

Reviewed by CopyMark Law Group

Reg. 4934644Status 404
Filing date
Status date
Registration date
Apr 12, 2016
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
POST REGISTRATION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CELLGRAFT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bruce S. Londa

Bruce S. Londa Norris McLaughlin P.A.7 Times SquareNew York, NY 10036-6524UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations for medical or veterinary purposes, in particular cells for the therapy of acute and chronic diseases, namely, orthopedic, diabetic, heart, ischemic, circulatory and neural diseases; diagnostic preparations for medical purposes; surgical implants comprised of living tissueSECTION 71 - CANCELLED—
035Marketing services; advertising services; wholesale and retail trading services relating to medical instruments and apparatus through direct solicitation by authorized sales representatives; advertising and advertising services, namely, development of advertising campaigns and distribution of advertising materials for othersSECTION 71 - CANCELLED—
041Educational services, namely, organization, arranging and conducting of courses, seminars, workshops, symposiums, congresses and conferences in the field of regenerative medicine, wound healing, autoimmune diseases and reconstructive surgery; publication of printed matter, including in electronic form, other than advertising textsSECTION 71 - CANCELLED—
042conducting scientific researches; surveying; scientific research; biological, chemical and medical research, including the development of new therapies, in particular cell therapies; research in the field of cell-based therapiesSECTION 71 - CANCELLED—
044Medical services; human hygiene and beauty care; medical treatment of acute and chronic diseases in humans and animals, namely, degenerative arthritis, chronic wounds and ulcers, neurological diseases, ischemic heart diseases, diabetes, stroke, autoimmune diseases; providing medical consultation and information in medical matters; anti-ageing therapy, namely, the rejuvenation of the skin by autologous regenerative cells of adipose tissues; cell-based therapies, namely, therapy with regenerative cells of the autologous adipose tissue; cell therapy, namely, therapy with regenerative cells of the autologous adipose tissueSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 27, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 27, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Aug 13, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jul 23, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 23, 2023INPCINVALIDATION PROCESSED—
Jun 19, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 19, 2022C71TCANCELLED SECTION 71—
Apr 12, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Feb 6, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 5, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 14, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 14, 2016FIMPFINAL DISPOSITION PROCESSED—
Jul 12, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 12, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 26, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 26, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 6, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 17, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 17, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Dec 17, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Dec 17, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Dec 17, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 12, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 11, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 12, 2015RFNTREFUSAL PROCESSED BY IB—
Aug 24, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 24, 2015RFRRREFUSAL PROCESSED BY MPU—
Aug 22, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 21, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 18, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 14, 2015DOCKASSIGNED TO EXAMINER—
Aug 14, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 13, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance